Company news

Suzhou Medicalsystem Technology Co., Ltd. Class A (SSE:603990) news

Suzhou Medicalsystem Technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 3, 2026: "SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement…

View Suzhou Medicalsystem Technology Co., Ltd. Class A →

Press releases & updates

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Redemption of Cash Management Products Purchased with Certain Idle Raised Funds

September 2, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Resolutions of the 43rd Meeting of the 4th Board of Directors

August 26, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading

August 6, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Redemption of Certain Idle Raised Funds Used for Cash Management

July 22, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Completing Industrial and Commercial Change Registration

July 21, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Semi-annual Performance Forecast for 2026

July 14, 2026

"SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD."Announcement on Redemption of Partial Idle Raised Funds Used for Cash Management

July 2, 2026

Announcement on Result of Shareholding Reduction by Shareholder

June 25, 2026

Announcement on Redemption of Partial Idle Raised Funds Used for Cash Management

June 24, 2026

Announcement on Signing Daily Operation Contracts

June 23, 2026

Announcement on Cancellation of Repurchased Shares and Share Changes

June 17, 2026

Announcement on Convening the Q1 2026 Performance Briefing

May 20, 2026

Announcement on Resolutions of the 42nd Meeting of the 4th Board of Directors

April 28, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

April 10, 2026

Announcement on Convening the 2025 Annual Performance Briefing

April 2, 2026

Announcement on Shareholding Reduction Plan for Shareholders

March 22, 2026

Announcement on Change of Independent Financial Advisor Sponsor

March 5, 2026

Announcement on Early Return of Raised Funds Temporarily Used to Supplement Current Capital

March 2, 2026

Earnings Preannouncement for 2025 (Updated Version)

January 29, 2026

Announcement on Receipt of the Remaining Transaction Proceeds from the Major Asset Sale

January 26, 2026

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale

January 12, 2026

Announcement on Resolutions of the 40th Meeting of the 4th Board of Directors

December 29, 2025

Announcement on Adding Extraordinary Proposal to the 3rd Extraordinary General Meeting in 2025

December 19, 2025

Announcement on Resolutions of the 20th Meeting of the 4th Board of Supervisors

December 12, 2025

Announcement on Renewing Engagement of Financial and Internal Control Audit Institutions for 2025

November 25, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 4, 2025

Announcement on Resolutions of the 19th Meeting of the 4th Board of Supervisors

October 29, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

October 13, 2025

Notice on Convening the 2nd Extraordinary General Meeting in 2025

September 26, 2025

Announcement on Completion of Non-Trade Transfer for the Repurchase of Unlocked Shares under the Phase III Employee Stock Ownership Plan

September 8, 2025

Announcement on Fulfillment of Shareholder Performance Commitments

August 27, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

August 25, 2025

Announcement on Repurchase of Unlocked Shares under the Phase III Employee Stock Ownership Plan and Termination of Phase III Employee Stock Ownership Plan

August 19, 2025

Announcement on Expiration of the Lock-up Period and Achievements of Unlocking Conditions for Employee Stock Ownership Plan (Phase III)

July 24, 2025

Announcement on Completing Industrial and Commercial Change Registration

July 15, 2025

Semi-annual Earnings Preannouncement for 2025

July 2, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

June 30, 2025

Announcement on Cancellation and Opening of Special Accounts for Raised Funds and Signing of Tripartite and Quadripartite Supervision Agreements for Raised Funds

June 25, 2025

Announcement on Unrecovered Losses Reaching One-Third of Total Paid-in Share Capital in 2024

June 13, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 20, 2025

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

May 8, 2025

Announcement on Requesting the General Meeting to Authorize Board of Directors to Issue Shares to Specific Objects by Summary Procedure

April 29, 2025